Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Pre-incisional Intravenous Ibuprofen to Reduce Postoperative Pain and Opioid Dependence After Posterior Cervical or Lumbar Instrumented Spine Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients older than 18 years of age~* Able to give consent~* Diagnosed with spondylosis, stenosis, and/or instability of the cervical spine~* Diagnosed with spondylosis, stenosis, and/or instability of the lumbar spine~* Require a posterior decompression with internal fixation~* Likely to complete the trial~Exclusion Criteria:~* Patients with previous surgery at the treated spine segment~* Women who are pregnant or plan to become pregnant during the study period Renal/liver disease~* Anemia; coagulopathy~* Thrombocytopenia (\<30,000)~* Coronary artery disease~* Previous coronary artery bypass graft (CABG)~* Patients taking Coumadin, Plavix, Lithium, or ACE-inhibitors plus Lasix; non-steroidal anti-inflammatory drug (NSAID) hypersensitivity~* Gastric ulcers~* Recent stroke~* Traumatic brain injury, or intracranial surgery

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intravenous (IV) ibuprofen (Type: ACTIVE_COMPARATOR): 800mg IV ibuprofen before incision, followed by four total scheduled doses of IV ibuprofen every six hours for 24 hours, in addition to whatever narcotic or other pain control regimens prescribed by the treating physician to control postoperative pain.
- Intravenous (IV) normal saline (Type: PLACEBO_COMPARATOR): 800mg normal saline before incision, followed by four total scheduled doses of IV ibuprofen every six hours for 24 hours, in addition to whatever narcotic or other pain control regimens prescribed by the treating physician to control postoperative pain.

Based on this trial design, predict the completion outcome and termination type (if applicable).